Exclusive

Publication

Byline

Location

AdCella and Shanghai Cell Therapy Group launch global collaboration on groundbreaking cancer therapy

Singapore, Jan. 15 -- Australia-based AdAlta Limited, developer of next generation cell and protein therapeutic products, and its cellular immunotherapy subsidiary, AdCella have signed a major develop... Read More


ElpasBio and Fosun Kairos collaborate to commercialise AlloJoin(R) stem cell therapy

Singapore, Jan. 15 -- China-based startup ElpasBio Holdings, a leading clinical-stage biotechnology company focused on regenerative medicine, has entered into a collaboration agreement with Fosun Kair... Read More


Rakuten Medical and Lotte Biologics ink agreement to support biopharma in global oncology programme

Singapore, Jan. 14 -- US-based Rakuten Medical, Inc. and South Korea's Lotte Biologics have signed a biopharmaceutical contract manufacturing agreement duringthe J.P. Morgan Healthcare Conferencein Sa... Read More


Taiwan's Leadgene Biosolutions expands product portfolio for metabolic research

Singapore, Jan. 14 -- Taiwan-based startup Leadgene Biosolutions has announced the expansion of its product portfolio following its strategic integration into Leadgene Biomedical. The expanded portfol... Read More


Curi Bio launches Asia-Pacific hub following full acquisition of Quvit Bio in South Korea

Singapore, Jan. 13 -- US-based Curi Bio, the leader in delivering human-relevant functional data for drug discovery and development, has announced the formal establishment of Curi Bio Co., Ltd., a who... Read More


Novartis to build 4th radioligand therapy facility in US, expanding $23 B investment

Singapore, Jan. 13 -- Novartis, a leading global innovative medicines company, has announced plans to build its fourth US radioligand therapy (RLT) manufacturing facility in Winter Park, Florida, US. ... Read More


Nuvation Bio and Eisai license Taletrectinib rights outside US, China and Japan for $230 M

Singapore, Jan. 13 -- US-based Nuvation Bio Inc., a global oncology company focused on tackling some of the toughest challenges in cancer treatment, and Japan's Eisai Co., Ltd, a human-centered global... Read More


SK bioscience and Sanofi launch MenQuadfi meningococcal vaccine in Korea

Singapore, Jan. 12 -- SK bioscience has announced the new domestic launch of MenQuadfi Injection (MenQuadfi, MenACWY-TT), a quadrivalent meningococcal conjugate vaccine, in partnership with the Korean... Read More


Japan's Takeda partners with Halozyme to continue advancing Vedolizumab with ENHANZE(R) drug-delivery technology

Singapore, Jan. 12 -- Japanese pharmaceutical firm Takeda has announced a global collaboration and license agreement with US-based Halozyme Therapeutics, Inc., granting Takeda exclusive access to Halo... Read More


China's MediLink signs additional exclusive licensing deal with Roche for $570 M

Singapore, Jan. 12 -- China-based MediLink Therapeutics has entered into a new collaboration and exclusive licensing agreement with Roche for the development and commercialisation of YL201, an investi... Read More